Nanofibrous bicomponent scaffolds for the dual delivery of NGF and GDNF: controlled release of growth factors and their biological effects
Electrospun fibrous scaffolds able to offering twin progress issue supply in a managed method have distinctive benefits for tissue engineering. On this examine, we’ve got investigated the formation, construction, and traits/properties of fibrous bicomponent scaffolds for the twin supply of glial cell line-derived neurotrophic issue (GDNF) and nerve progress issue (NGF) for peripheral nerve tissue regeneration.
GDNF and NGF have been integrated into core-shell structured poly(lactic-co-glycolic acid) (PLGA) and poly (D,L-lactic acid) (PDLLA) nanofibers, respectively, by way of emulsion electrospinning. Utilizing dual-source dual-power electrospinning, bicomponent scaffolds composed of GDNF/PLGA fibers and NGF/PDLLA fibers with totally different fiber part ratios have been produced.
The construction, properties, and in vitro launch habits of mono- and bicomponent scaffolds have been systematically investigated. Concurrent and sustained launch of GDNF and NGF from bicomponent scaffolds was achieved and their launch profiles could possibly be tuned. In vitro organic investigations have been carried out. Rat pheochromocytoma cells have been discovered to connect, unfold, and proliferate on all scaffolds.
The discharge of progress components from scaffolds may induce a lot improved neurite outgrowth and neural differentiation. GDNF and NGF launched from GDNF/PLGA scaffolds and NGF/PDLLA scaffolds, respectively, may induce dose-dependent neural differentiation individually. GDNF and NGF launched from bicomponent scaffolds exerted a synergistic impact on selling neural differentiation.
Redox proteomics reveals an interdependence of redox modification and placement of adhesome proteins in NGF-treated PC12 cells
Proteomics research have revealed that adhesomes are assembled from a plethora of proteins at integrin-mediated mobile contact websites with the extracellular matrix. By combining dimedone-trapping of sulfenylated proteins with the purification of the adhesome complicated, we prolonged earlier proteomics approaches on adhesomes to a redox proteomic evaluation. This added a brand new side of adhesome complexity as particular person adhesome proteins change their redox state in response to environmental alerts.
As mannequin system, rat pheochromocytoma PC12 cells have been studied in touch with sort IV collagen and in response to nerve progress issue (NGF). NGF stimulates the endogenous manufacturing of reactive oxygen species (ROS) and the formation of neurite-like cell protrusions, that are anchored to the substratum by way of adhesomes.
Dimedone detects the reversible oxidation of cysteine thiol teams into sulfenic acid teams which was utilized in proteomic evaluation of adhesome proteins revealing that sulfenation and placement of proteins mutually affect one another. For some proteins, recognized by the redox proteomics method, amongst them Nck-associated protein-1 (Nap-1), proximity ligation evaluation and co-immunoprecipitation assays proved that protein sulfenylation websites colocalize with adhesomes of protrusions.
In conclusion, the suprastructural composition and performance of adhesomes is redox-regulated by ROS. Of curiosity on this respect, isoform-selective pharmacological inhibition of NADPH-oxidases (Noxs) decreased the adhesomal location of the collagen-binding α1β1 integrin and the size of the outgrowing neurites, indicative of a task of Nox isoforms within the redox-regulation of adhesomes. Thus, our novel redox proteomics method not solely revealed redox-modifications and the potential redox-regulation of adhesomes and their constituents however it could additionally present a device to research the ROS-stimulated neurite restore of peripheral neurons.
NGF– and BDNF-dependent DRG sensory neurons deploy distinct degenerative signaling mechanisms
The nerve progress issue (NGF) and brain-derived neurotrophic issue (BDNF) are trophic components required by distinct inhabitants of sensory neurons throughout improvement of the nervous system. Neurons that fail to obtain acceptable trophic help are misplaced throughout this era of naturally occurring cell loss of life. Within the final decade, our understanding of the signalling pathways regulating neuronal loss of life following NGF deprivation has superior considerably. Nevertheless, the signaling mechanisms selling BDNF-deprivation induced sensory neuron degeneration are largely unknown.

Utilizing a well-established in vitro tradition mannequin of dorsal root ganglion (DRG), we’ve got examined degeneration mechanisms triggered upon BDNF withdrawal in sensory neurons. Our outcomes point out variations and similarities between the molecular signalling pathways behind NGF and BDNF deprivation-induced loss of life. For example, we noticed that the inhibition of Trk receptors (Okay252a), PKC (Gö6976), protein translation (cycloheximide) or caspases (zVAD-fmk) gives safety from NGF deprivation-induced loss of life however not from degeneration evoked by BDNF-withdrawal.
Curiously, degeneration of BDNF-dependent sensory neurons requires BAX and seems to depend on reactive oxygen species era slightly than caspases to induce degeneration. These outcomes spotlight the complexity and divergence of mechanisms regulating developmental sensory neuron loss of life.
Important assertion The elimination of neuronal cells generated in extra throughout embryonic phases characterizes the maturation of the nervous system. Right here we deal with the developmental cell loss of life mechanisms of BDNF-dependent dorsal root ganglion neurons in vitro, evaluating and distinction them with these deployed in NGF-dependent sensory neurons.
We observe a number of necessary variations between the molecular signalling pathways behind NGF and BDNF deprivation-induced loss of life. Considerably, degeneration of BDNF-dependent sensory neurons requires BAX however not caspase activation, as an alternative reactive oxygen species era seems to play a key position in degeneration. This work highlights the complexity of cell loss of life mechanisms in distinct embryonic sensory neuron populations.
Native injections of β-NGF accelerates endochondral fracture restore by selling cartilage to bone conversion
There are at present no pharmacological approaches in fracture therapeutic designed to therapeutically stimulate endochondral ossification. On this examine, we take a look at nerve progress issue (NGF) as an understudied therapeutic for fracture restore. We first characterised endogenous expression of Ngf and its receptor tropomyosin receptor kinase A (TrkA) throughout tibial fracture restore, discovering that they peak in the course of the cartilaginous section.
We then examined two injection regimens and located that native β-NGF injections in the course of the endochondral/cartilaginous section promoted osteogenic marker expression. Gene expression knowledge from β-NGF stimulated cartilage callus explants present a promotion in markers related to endochondral ossification resembling Ihh, Alpl, and Sdf-1. Gene ontology enrichment evaluation revealed the promotion of genes related to Wnt activation, PDGF- and integrin-binding.
Subsequent histological evaluation confirmed Wnt activation following native β-NGF injections. Lastly, we reveal useful enhancements to bone therapeutic following native β-NGF injections which resulted in a lower in cartilage and improve of bone quantity. Furthermore, the newly fashioned bone contained larger trabecular quantity, connective density, and bone mineral density.
NGFRAP1 Peptide |
46-876P |
ProSci |
0.1 mg |
EUR 405.6 |
Description: NGFRAP1 Peptide |
NGFRAP1 siRNA |
20-abx903554 |
Abbexa |
|
|
|
NGFRAP1 siRNA |
20-abx925863 |
Abbexa |
|
|
|
NGFRAP1 siRNA |
20-abx925864 |
Abbexa |
|
|
|
BEX3 Antibody / NGFRAP1 / NADE |
RQ6827 |
NSJ Bioreagents |
100ug |
EUR 419 |
Description: Protein BEX3 is a protein that in humans is encoded by the BEX3 gene. BEX3 (brain-expressed X-linked protein 3), also called NGFRAP1 (nerve growth factor receptor associated protein 1), NADE (p75NTR-associated death executor) or FAP-1 (Fas-associated phosphatase-1), is a 24 kDa member of the BEX protein family. A nuclear export signal (aa 77-87) allows NGFRAP1 to export bound p75NTR. It is widely expressed, but highest in ovarian granulosa cells, testis, prostate, seminal vesicle and liver. Except for a 13-19 amino acid (aa) rodent Arg/His region at aa 35 that is not found in humans, human NGFRAP1 shares 94% aa identity with mouse and rat NGFRAP1. In humans, a 101 aa isoform with an alternative start site at aa 11 has been described. |
NGFRAP1 Rabbit pAb |
A7296-100ul |
Abclonal |
100 ul |
EUR 369.6 |
NGFRAP1 Rabbit pAb |
A7296-200ul |
Abclonal |
200 ul |
EUR 550.8 |
NGFRAP1 Rabbit pAb |
A7296-20ul |
Abclonal |
20 ul |
EUR 219.6 |
NGFRAP1 Rabbit pAb |
A7296-50ul |
Abclonal |
50 ul |
EUR 267.6 |
Polyclonal NGFRAP1 / NADE / Bex Antibody |
APR02251G |
Leading Biology |
0.05mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NGFRAP1 / NADE / Bex . This antibody is tested and proven to work in the following applications: |
Polyclonal NGFRAP1 Antibody (C-Term) |
APG00487G |
Leading Biology |
0.1mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human NGFRAP1 (C-Term). This antibody is tested and proven to work in the following applications: |
Human NGFRAP1 shRNA Plasmid |
20-abx958923 |
Abbexa |
|
|
|
Mouse NGFRAP1 shRNA Plasmid |
20-abx969345 |
Abbexa |
|
|
|
Rat NGFRAP1 shRNA Plasmid |
20-abx987406 |
Abbexa |
|
|
|
Human Protein BEX3 (NGFRAP1) |
1-CSB-EP015781HU |
Cusabio |
-
EUR 456.00
-
EUR 256.80
-
EUR 1570.80
-
EUR 672.00
-
EUR 1047.60
-
EUR 314.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human Protein BEX3(NGFRAP1) expressed in E.coli |
Human Protein BEX3 (NGFRAP1) |
1-CSB-YP015781HU |
Cusabio |
-
EUR 516.00
-
EUR 280.80
-
EUR 1809.60
-
EUR 770.40
-
EUR 1210.80
-
EUR 349.20
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human Protein BEX3(NGFRAP1) expressed in Yeast |
Monoclonal NGFRAP1 Antibody (monoclonal) (M01), Clone: 4E6 |
AMM03857G |
Leading Biology |
0.1mg |
EUR 580.8 |
Description: A Monoclonal antibody against Human NGFRAP1 (monoclonal) (M01). The antibodies are raised in mouse and are from clone 4E6. This antibody is applicable in WB, E |
Ngfrap1 ORF Vector (Rat) (pORF) |
ORF071295 |
ABM |
1.0 ug DNA |
EUR 607.2 |
NGFRAP1 ORF Vector (Human) (pORF) |
ORF007064 |
ABM |
1.0 ug DNA |
EUR 114 |
Ngfrap1 ORF Vector (Mouse) (pORF) |
ORF051344 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Ngfrap1 ORF Vector (Mouse) (pORF) |
ORF051345 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Ngfrap1 ORF Vector (Mouse) (pORF) |
ORF051346 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Ngfrap1 sgRNA CRISPR Lentivector set (Rat) |
K6661501 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
NGFRAP1 sgRNA CRISPR Lentivector set (Human) |
K1424801 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
Ngfrap1 sgRNA CRISPR Lentivector set (Mouse) |
K3657401 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
Nerve Growth Factor Receptor-Associated Protein 1 (NGFRAP1) Antibody |
20-abx005503 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
Nerve Growth Factor Receptor-Associated Protein 1 (NGFRAP1) Antibody |
abx029967-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
Nerve Growth Factor Receptor-Associated Protein 1 (NGFRAP1) Antibody |
abx029967-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
Nerve Growth Factor Receptor-Associated Protein 1 (NGFRAP1) Antibody |
abx433035-200ul |
Abbexa |
200 ul |
EUR 343.2 |
|
Nerve Growth Factor Receptor-Associated Protein 1 (NGFRAP1) Antibody |
abx235721-100ug |
Abbexa |
100 ug |
EUR 610.8 |
|
Ngfrap1 sgRNA CRISPR Lentivector (Rat) (Target 1) |
K6661502 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Ngfrap1 sgRNA CRISPR Lentivector (Rat) (Target 2) |
K6661503 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Ngfrap1 sgRNA CRISPR Lentivector (Rat) (Target 3) |
K6661504 |
ABM |
1.0 ug DNA |
EUR 184.8 |
NGFRAP1 sgRNA CRISPR Lentivector (Human) (Target 1) |
K1424802 |
ABM |
1.0 ug DNA |
EUR 184.8 |
NGFRAP1 sgRNA CRISPR Lentivector (Human) (Target 2) |
K1424803 |
ABM |
1.0 ug DNA |
EUR 184.8 |
NGFRAP1 sgRNA CRISPR Lentivector (Human) (Target 3) |
K1424804 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Ngfrap1 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
K3657402 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Ngfrap1 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
K3657403 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Ngfrap1 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
K3657404 |
ABM |
1.0 ug DNA |
EUR 184.8 |
NGFRAP1 Protein Vector (Human) (pPB-C-His) |
PV028253 |
ABM |
500 ng |
EUR 394.8 |
NGFRAP1 Protein Vector (Human) (pPB-N-His) |
PV028254 |
ABM |
500 ng |
EUR 394.8 |
NGFRAP1 Protein Vector (Human) (pPM-C-HA) |
PV028255 |
ABM |
500 ng |
EUR 394.8 |
NGFRAP1 Protein Vector (Human) (pPM-C-His) |
PV028256 |
ABM |
500 ng |
EUR 394.8 |
NGFRAP1 Protein Vector (Mouse) (pPB-C-His) |
PV205374 |
ABM |
500 ng |
EUR 723.6 |
NGFRAP1 Protein Vector (Mouse) (pPB-N-His) |
PV205375 |
ABM |
500 ng |
EUR 723.6 |
NGFRAP1 Protein Vector (Mouse) (pPM-C-HA) |
PV205376 |
ABM |
500 ng |
EUR 723.6 |
NGFRAP1 Protein Vector (Mouse) (pPM-C-His) |
PV205377 |
ABM |
500 ng |
EUR 723.6 |
NGFRAP1 Protein Vector (Mouse) (pPB-C-His) |
PV205378 |
ABM |
500 ng |
EUR 723.6 |
NGFRAP1 Protein Vector (Mouse) (pPB-N-His) |
PV205379 |
ABM |
500 ng |
EUR 723.6 |
NGFRAP1 Protein Vector (Mouse) (pPM-C-HA) |
PV205380 |
ABM |
500 ng |
EUR 723.6 |
NGFRAP1 Protein Vector (Mouse) (pPM-C-His) |
PV205381 |
ABM |
500 ng |
EUR 723.6 |
NGFRAP1 Protein Vector (Mouse) (pPB-C-His) |
PV205382 |
ABM |
500 ng |
EUR 723.6 |
NGFRAP1 Protein Vector (Mouse) (pPB-N-His) |
PV205383 |
ABM |
500 ng |
EUR 723.6 |
NGFRAP1 Protein Vector (Mouse) (pPM-C-HA) |
PV205384 |
ABM |
500 ng |
EUR 723.6 |
NGFRAP1 Protein Vector (Mouse) (pPM-C-His) |
PV205385 |
ABM |
500 ng |
EUR 723.6 |
NGFRAP1 3'UTR GFP Stable Cell Line |
TU065657 |
ABM |
1.0 ml |
EUR 1672.8 |
Ngfrap1 3'UTR GFP Stable Cell Line |
TU263958 |
ABM |
1.0 ml |
Ask for price |
NGFRAP1 3'UTR Luciferase Stable Cell Line |
TU015657 |
ABM |
1.0 ml |
EUR 1672.8 |
Ngfrap1 3'UTR Luciferase Stable Cell Line |
TU114063 |
ABM |
1.0 ml |
Ask for price |
Ngfrap1 3'UTR GFP Stable Cell Line |
TU164063 |
ABM |
1.0 ml |
Ask for price |
NGFRAP1 Protein Vector (Rat) (pPB-C-His) |
PV285178 |
ABM |
500 ng |
EUR 723.6 |
NGFRAP1 Protein Vector (Rat) (pPB-N-His) |
PV285179 |
ABM |
500 ng |
EUR 723.6 |
NGFRAP1 Protein Vector (Rat) (pPM-C-HA) |
PV285180 |
ABM |
500 ng |
EUR 723.6 |
NGFRAP1 Protein Vector (Rat) (pPM-C-His) |
PV285181 |
ABM |
500 ng |
EUR 723.6 |
Ngfrap1 3'UTR Luciferase Stable Cell Line |
TU213958 |
ABM |
1.0 ml |
Ask for price |
NGFRAP1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV) |
LV652789 |
ABM |
1.0 ug DNA |
EUR 616.8 |
NGFRAP1 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
LV652793 |
ABM |
1.0 ug DNA |
EUR 616.8 |
NGFRAP1 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
LV652794 |
ABM |
1.0 ug DNA |
EUR 616.8 |
Recombinant Nerve Growth Factor Receptor Associated Protein 1 (NGFRAP1) |
4-RPD932Ra01 |
Cloud-Clone |
-
EUR 657.60
-
EUR 300.00
-
EUR 2136.00
-
EUR 792.00
-
EUR 1464.00
-
EUR 516.00
-
EUR 5160.00
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Rat Nerve Growth Factor Receptor Associated Protein 1 expressed in: E.coli |
Ngfrap1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
K6661505 |
ABM |
3 x 1.0 ug |
EUR 451.2 |
NGFRAP1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
K1424805 |
ABM |
3 x 1.0 ug |
EUR 451.2 |
Ngfrap1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
K3657405 |
ABM |
3 x 1.0 ug |
EUR 451.2 |
Ngfrap1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
K6661506 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Ngfrap1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
K6661507 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Ngfrap1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
K6661508 |
ABM |
1.0 ug DNA |
EUR 200.4 |
NGFRAP1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA) |
LV652790 |
ABM |
1.0 ug DNA |
EUR 616.8 |
NGFRAP1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
LV652791 |
ABM |
1.0 ug DNA |
EUR 686.4 |
NGFRAP1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
LV652792 |
ABM |
1.0 ug DNA |
EUR 686.4 |
NGFRAP1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
K1424806 |
ABM |
1.0 ug DNA |
EUR 200.4 |
NGFRAP1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
K1424807 |
ABM |
1.0 ug DNA |
EUR 200.4 |
NGFRAP1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
K1424808 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Ngfrap1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
K3657406 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Ngfrap1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
K3657407 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Ngfrap1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
K3657408 |
ABM |
1.0 ug DNA |
EUR 200.4 |
ASAP1 antibody Antibody |
DF8746 |
Affbiotech |
200ul |
EUR 420 |
anti- Antibody^Polyclonal antibody control antibody |
LSMab09882 |
Lifescience Market |
100 ug |
EUR 525.6 |
ARHGDIA Antibody / RHOGDI Antibody |
F54788-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 165 |
ARHGDIA Antibody / RHOGDI Antibody |
F54788-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 379 |
Antibody |
A1360-500 |
Biovision |
each |
Ask for price |
Anti-Glycolipid Antibody (AGA) Antibody |
20-abx004855 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
20-abx008109 |
Abbexa |
-
EUR 360.00
-
EUR 526.80
-
EUR 226.80
|
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
20-abx123734 |
Abbexa |
|
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
20-abx014333 |
Abbexa |
-
EUR 376.80
-
EUR 117.60
-
EUR 477.60
-
EUR 594.00
|
- 100 ug
- 10 ug
- 200 ug
- 300 µg
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
abx033330-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
Ly1 Antibody Reactive (LYAR) Antibody |
abx033330-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
Anti-Glycolipid Antibody (AGA) Antibody |
abx036399-100ug |
Abbexa |
100 ug |
EUR 469.2 |
|
Anti-Glycoprotein Antibody (GP) Antibody |
20-abx319900 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Anti-Glycoprotein Antibody (GP) Antibody |
20-abx319901 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Anti-Glycoprotein Antibody (GP) Antibody |
20-abx319905 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Anti-Glycoprotein Antibody (GP) Antibody |
20-abx319913 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Anti-Glycolipid Antibody (AGA) Antibody |
abx230204-100ug |
Abbexa |
100 ug |
EUR 577.2 |
|
Ly1 Antibody Reactive (LYAR) Antibody |
20-abx324434 |
Abbexa |
|
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
20-abx311665 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
abx234901-100ug |
Abbexa |
100 ug |
EUR 661.2 |
|
Anti-Anti-SEPT6 antibody antibody |
STJ11100949 |
St John's Laboratory |
100 µl |
EUR 332.4 |
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis. One version of pediatric acute myeloid leukemia is the result of a reciprocal translocation between chromosomes 11 and X, with the breakpoint associated with the genes encoding the mixed-lineage leukemia and septin 2 proteins. This gene encodes four transcript variants encoding three distinct isoforms. An additional transcript variant has been identified, but its biological validity has not been determined. |
Anti-Anti-SEPT9 Antibody antibody |
STJ111369 |
St John's Laboratory |
100 µl |
EUR 332.4 |
Description: This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described. |
Anti-Anti-SEPT4 Antibody antibody |
STJ112276 |
St John's Laboratory |
100 µl |
EUR 332.4 |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is highly expressed in brain and heart. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. One of the isoforms (known as ARTS) is distinct; it is localized to the mitochondria, and has a role in apoptosis and cancer. |
Anti-Anti-SEPT5 Antibody antibody |
STJ114819 |
St John's Laboratory |
100 µl |
EUR 332.4 |
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
Anti-Anti-SEPT7 Antibody antibody |
STJ116214 |
St John's Laboratory |
100 µl |
EUR 332.4 |
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
Anti-Anti-SEPT8 Antibody antibody |
STJ117206 |
St John's Laboratory |
100 µl |
EUR 332.4 |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
Anti-Anti-SEPT12 Antibody antibody |
STJ117759 |
St John's Laboratory |
100 µl |
EUR 332.4 |
Description: This gene encodes a guanine-nucleotide binding protein and member of the septin family of cytoskeletal GTPases. Septins play important roles in cytokinesis, exocytosis, embryonic development, and membrane dynamics. Multiple transcript variants encoding different isoforms have been found for this gene. |
Anti-Anti-SEPT7 Antibody antibody |
STJ28963 |
St John's Laboratory |
100 µl |
EUR 332.4 |
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
Anti-Anti-SEPT5 Antibody antibody |
STJ25477 |
St John's Laboratory |
100 µl |
EUR 332.4 |
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
Anti-Anti-SEPT8 Antibody antibody |
STJ25479 |
St John's Laboratory |
100 µl |
EUR 332.4 |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
Anti-Anti-SEPT1 antibody antibody |
STJ119580 |
St John's Laboratory |
100 µl |
EUR 332.4 |
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis and the maintenance of cellular morphology. This gene encodes a protein that can form homo- and heterooligomeric filaments, and may contribute to the formation of neurofibrillary tangles in Alzheimer's disease. Alternatively spliced transcript variants have been found but the full-length nature of these variants has not been determined. [provided by RefSeq, Dec 2012] |
CLCN5 Antibody / CIC-5 antibody |
RQ6462 |
NSJ Bioreagents |
100ug |
EUR 419 |
Description: The CLCN5 gene encodes the chloride channel Cl-/H+ exchanger ClC-5. This gene encodes a member of the ClC family of chloride ion channels and ion transporters. The encoded protein is primarily localized to endosomal membranes and may function to facilitate albumin uptake by the renal proximal tubule. Mutations in this gene have been found in Dent disease and renal tubular disorders complicated by nephrolithiasis. Alternatively spliced transcript variants have been found for this gene. |
Cytokeratin 7 antibody-Cytoskeleton Marker Antibody |
48169-100ul |
SAB |
100ul |
EUR 399.6 |
Cytokeratin 7 antibody-Cytoskeleton Marker Antibody |
48169-50ul |
SAB |
50ul |
EUR 286.8 |
Anti CD22 Antibody: CD22 Monoclonal Antibody |
065-A-01mg |
Virogen |
0,1 mg |
EUR 321 |
|
Description: anti-CD22 monoclonal antibody |
Anti CD22 Antibody: CD22 Monoclonal Antibody |
065-A-1000ug |
Virogen |
1000 ug |
EUR 1539 |
|
Description: anti-CD22 monoclonal antibody |
Antibody Pair to ApoA-V antibody |
10R-1876 |
Fitzgerald |
100 ul |
EUR 781.2 |
Description: Mouse monoclonal Antibody Pair to ApoA-V antibody |
Ly1 Antibody Reactive Homolog (LYAR) Antibody |
20-abx103034 |
Abbexa |
-
EUR 543.60
-
EUR 159.60
-
EUR 1562.40
-
EUR 744.00
-
EUR 410.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Ly1 Antibody Reactive Homolog (LYAR) Antibody |
20-abx103035 |
Abbexa |
-
EUR 560.40
-
EUR 159.60
-
EUR 1612.80
-
EUR 760.80
-
EUR 410.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Ly1 Antibody Reactive Homolog (LYAR) Antibody |
20-abx103036 |
Abbexa |
-
EUR 577.20
-
EUR 159.60
-
EUR 1696.80
-
EUR 794.40
-
EUR 427.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Hepatitis C Virus Antibody (HCV) Antibody |
abx023924-1mg |
Abbexa |
1 mg |
EUR 1446 |
|
Anti-Glycoprotein Antibody (GP) Antibody (HRP) |
20-abx319902 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Anti-Glycoprotein Antibody (GP) Antibody (FITC) |
20-abx319903 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Anti-Glycoprotein Antibody (GP) Antibody (Biotin) |
20-abx319904 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Anti-Glycoprotein Antibody (GP) Antibody (HRP) |
20-abx319906 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Anti-Glycoprotein Antibody (GP) Antibody (FITC) |
20-abx319907 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Anti-Glycoprotein Antibody (GP) Antibody (Biotin) |
20-abx319908 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Anti-Glycoprotein Antibody (GP) Antibody (HRP) |
20-abx319914 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Collectively, we reveal β-NGF’s capability to advertise endochondral restore in a murine mannequin and uncover mechanisms that may serve to additional perceive the molecular switches that happen throughout cartilage to bone transformation.
Tags :
dna,
dna ancestry,
dna block,
dna bts,
dna genetics,
dna hr block,
dna hrblock login,
dna lyrics,
dna motoring,
dna painter,
dna productions,
dna replication,
dna song,
dna study slavery,
dna template sequence,
dna template slippage,
dna template strand,
dna template strand and non-template strand,
dna template strand and rna strand,
dna template strand coding strand,
dna template strand definition,
dna template strand meaning,
dna template strand mrna,
dna template strand read in what direction,
dna template strand role in transcription,
dna template strand sequencing,
dna template strand to amino acid translation,
dna template strand transcription,
dna template strand translation,
exosomes 5g,
exosomes and chf,
exosomes and coronavirus,
exosomes and ed,
exosomes and ms,
exosomes and ra,
exosomes and viruses,
exosomes are virus,
exosomes dr kaufman,
exosomes for delivery,
exosomes for hair,
exosomes for hair loss,
exosomes msc,
exosomes nj,
exosomes tem,
exosomes therapy,
exosomes treatment,
gels iga,
gels iga st henry ohio,
gels kitchen,
gelsemium,
gelsemium homeopathic,
gelsemium sempervirens,
gelsenkirchen,
gelsey kirkland,
gelsey kirkland 2020,
gelsolin,
gelson’s instacart,
gelson’s market